Boudewijn L. DeJonge, n/a

Director Microbiology
Shionogi Inc.

Poster(s):

• (473) Comparative Activity of Cefiderocol on Bloodstream Infection Isolates From U.S. ICU Patients
  Tuesday, January 23, 2024

  8:45 AM – 9:45 AM MT

• (485) Cefiderocol Activity for Carbapenem-Nonsusceptible Bacteria From Intensive Care Pneumonia Patients
  Sunday, January 21, 2024

  9:45 AM – 10:45 AM MT